Merit Medical Systems
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Merit Medical Systems's revenues will expand 11.9% and EPS will wane -38.1%.
The average estimate for revenue is $112.4 million. On the bottom line, the average EPS estimate is $0.13.
Last quarter, Merit Medical Systems booked revenue of $103.9 million. GAAP reported sales were 8.7% higher than the prior-year quarter's $95.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.10. GAAP EPS of $0.02 for Q1 were 86% lower than the prior-year quarter's $0.14 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 41.4%, 480 basis points worse than the prior-year quarter. Operating margin was 2.2%, 640 basis points worse than the prior-year quarter. Net margin was 0.6%, 540 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $446.6 million. The average EPS estimate is $0.51.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 85 members out of 90 rating the stock outperform, and five members rating it underperform. Among 24 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give Merit Medical Systems a green thumbs-up, and give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Merit Medical Systems is outperform, with an average price target of $15.40.
Is Merit Medical Systems the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Merit Medical Systems to My Watchlist.